Physician profile
Sheetal Dhote
NPI 1376707174
$952.45
in general payments reported to CMS, 2019-2025
17 companies · $136 in 2025
The $136 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $45.30 · 2021: $86.53 · 2022: $276 · 2023: $215 · 2024: $55.09 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $139.09 | 2022-2023 | Kristalose |
| Corium, LLC | $135.68 | 2022-2025 | Azstarys |
| Sobi, INC | $98.18 | 2020-2023 | |
| Cranial Technologies, INC | $91.75 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $90.45 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $76.30 | 2020-2023 | Proquad, Vaxneuvance, Gardasil 9 |
| Collegium Pharmaceutical, INC. | $52.74 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $48.31 | 2019-2024 | Bexsero |
| Takeda Pharmaceuticals U.S.A., INC. | $36.07 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $31.14 | 2022-2023 | Flumist Quadrivalent |
| Pfizer INC. | $28.29 | 2019-2021 | |
| Neos Therapeutics, LP | $23.13 | 2019 | |
| Shire North American Group INC | $21.81 | 2019 | |
| Tris Pharma INC | $21.36 | 2025 | Dyanavel Xr |
| Medline Industries LP | $21.20 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $19.12 | 2024 | |
| Seqirus USA INC | $17.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheetal Dhote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.